Moneycontrol PRO
indoco remedies
Jump to
186 Results Found
  • Indoco Remedies Q3 PAT seen up 54.9% YoY to Rs 39.3 cr: Prabhudas Lilladher Jan 13, 2022 03:22 PM IST

    Indoco Remedies Q3 PAT seen up 54.9% YoY to Rs 39.3 cr: Prabhudas Lilladher

    Net Sales are expected to increase by 17.1 percent Y-o-Y (up 0.6 percent Q-o-Q) to Rs 389.2 crore, according to Prabhudas Lilladher.

  • Accumulate Indoco Remedies; target of Rs 480: Prabhudas Lilladher Nov 05, 2021 09:35 AM IST

    Accumulate Indoco Remedies; target of Rs 480: Prabhudas Lilladher

    Prabhudas Lilladher recommended accumulate rating on Indoco Remedies with a target price of Rs 480 in its research report dated November 04, 2021.

  • Indoco Remedies Consolidated September 2021 Net Sales at Rs 386.87 crore, up 17.86% Y-o-Y Nov 03, 2021 10:00 AM IST

    Indoco Remedies Consolidated September 2021 Net Sales at Rs 386.87 crore, up 17.86% Y-o-Y

  • Indoco Remedies Standalone September 2021 Net Sales at Rs 386.59 crore, up 17.99% Y-o-Y Nov 02, 2021 04:11 PM IST

    Indoco Remedies Standalone September 2021 Net Sales at Rs 386.59 crore, up 17.99% Y-o-Y

  • Hot Stocks | Here is why you should buy Indoco Remedies, Jindal Steel and Apollo Pipes for the short term Oct 21, 2021 07:34 AM IST

    Hot Stocks | Here is why you should buy Indoco Remedies, Jindal Steel and Apollo Pipes for the short term

    For trade in Nifty, we advise traders to wait for the prices to dip towards 18,100 –18,000 to initiate a fresh long position for an appropriate risk-reward ratio, said Rohan Patil of Bonanza Portfolio

  • Indoco Remedies Q2 PAT seen up 53.9% YoY to Rs 38.6 cr: Prabhudas Lilladher Oct 06, 2021 06:00 PM IST

    Indoco Remedies Q2 PAT seen up 53.9% YoY to Rs 38.6 cr: Prabhudas Lilladher

    Net Sales are expected to increase by 24.2 percent Y-o-Y (up 5.1 percent Q-o-Q) to Rs 400.5 crore, according to Prabhudas Lilladher.

  • Buy Indoco Remedies; target of Rs 575: ICICI Direct Aug 18, 2021 11:01 AM IST

    Buy Indoco Remedies; target of Rs 575: ICICI Direct

    ICICI Direct is bullish on Indoco Remedies has recommended buy rating on the stock with a target price of Rs 575 in its research report dated August 12, 2021.

  • Indoco Remedies Standalone June 2021 Net Sales at Rs 386.49 crore, up 40.1% Y-o-Y Aug 11, 2021 11:00 PM IST

    Indoco Remedies Standalone June 2021 Net Sales at Rs 386.49 crore, up 40.1% Y-o-Y

  • Indoco Remedies Consolidated June 2021 Net Sales at Rs 386.75 crore, up 40.2% Y-o-Y Aug 11, 2021 05:44 PM IST

    Indoco Remedies Consolidated June 2021 Net Sales at Rs 386.75 crore, up 40.2% Y-o-Y

  • Buy Indoco Remedies; target of Rs 390: ICICI Direct Jun 01, 2021 10:11 AM IST

    Buy Indoco Remedies; target of Rs 390: ICICI Direct

    ICICI Direct is bullish on Indoco Remedies has recommended buy rating on the stock with a target price of Rs 390 in its research report dated May 26, 2021.

  • Indoco Remedies Consolidated March 2021 Net Sales at Rs 305.14 crore, up 12.19% Y-o-Y May 26, 2021 01:55 PM IST

    Indoco Remedies Consolidated March 2021 Net Sales at Rs 305.14 crore, up 12.19% Y-o-Y

  • Indoco Remedies Standalone March 2021 Net Sales at Rs 304.85 crore, up 12.07% Y-o-Y May 26, 2021 01:33 PM IST

    Indoco Remedies Standalone March 2021 Net Sales at Rs 304.85 crore, up 12.07% Y-o-Y

  • Indoco Remedies share price jumps 5% on launching Brinzolamide Ophthalmic Suspension in US Mar 09, 2021 01:58 PM IST

    Indoco Remedies share price jumps 5% on launching Brinzolamide Ophthalmic Suspension in US

    The ANDA approved by the US Food and Drug Administration (US FDA) for Brinzolamide Ophthalmic Suspension 1 percent, is used to treat high pressure inside the eye due to ocular hypertension and open-angle glaucoma, the company said.

  • Buy Muthoot Finance; target of Rs 1479: Prabhudas Lilladher Feb 15, 2021 07:31 PM IST

    Buy Muthoot Finance; target of Rs 1479: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Muthoot Finance has recommended buy rating on the stock with a target price of Rs 1479 in its research report dated February 09, 2021.

  • Buy Indoco Remedies; target of Rs 358: Prabhudas Lilladher Feb 15, 2021 07:30 PM IST

    Buy Indoco Remedies; target of Rs 358: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Indoco Remedies has recommended buy rating on the stock with a target price of Rs 358 in its research report dated February 10, 2021.

  • Indoco Remedies Consolidated December 2020 Net Sales at Rs 332.29 crore, up 14.84% Y-o-Y Feb 09, 2021 01:11 PM IST

    Indoco Remedies Consolidated December 2020 Net Sales at Rs 332.29 crore, up 14.84% Y-o-Y

  • Indoco Remedies Standalone December 2020 Net Sales at Rs 331.94 crore, up 14.72% Y-o-Y Feb 09, 2021 01:11 PM IST

    Indoco Remedies Standalone December 2020 Net Sales at Rs 331.94 crore, up 14.72% Y-o-Y

  • Indoco Remedies Q3 PAT seen up 191.2% YoY to Rs. 9.3 cr: Prabhudas Lilladher Jan 18, 2021 11:11 PM IST

    Indoco Remedies Q3 PAT seen up 191.2% YoY to Rs. 9.3 cr: Prabhudas Lilladher

    Net Sales are expected to increase by 17.7 percent Y-o-Y (up 3.4 percent Q-o-Q) to Rs. 283.4 crore, according to Prabhudas Lilladher.

  • Buy Indoco Remedies; target of Rs 380: ICICI Direct Dec 30, 2020 12:42 PM IST

    Buy Indoco Remedies; target of Rs 380: ICICI Direct

    ICICI Securities is bullish on Indoco Remedies recommended buy rating on the stock with a target price of Rs 380 in its research report dated December 30, 2020.

  • Indoco Remedies share price falls nearly 7% despite tender win in Germany Dec 08, 2020 12:09 PM IST

    Indoco Remedies share price falls nearly 7% despite tender win in Germany

    The share is trading 4.45 percent below its 52-week high and 104.58 percent above its 52-week low.

  • Indoco Remedies share price hits 52-week high after Dovetail India Fund buys 5 lakh shares Dec 03, 2020 12:24 PM IST

    Indoco Remedies share price hits 52-week high after Dovetail India Fund buys 5 lakh shares

    Dovetail India Fund purchased 5 lakh equity shares resulting in 0.58 percent stake at Rs 265.31 per share, data available on BSE showed. However, OHM Juniper Longterm Fund offloaded 0.54 percent stake in the company at a share price of Rs 265.31 per share.

  • Tata Sons buys 0.7% stake in Tata Chemicals, Adani Logistics continues to offload stake in Snowman Dec 02, 2020 10:07 PM IST

    Tata Sons buys 0.7% stake in Tata Chemicals, Adani Logistics continues to offload stake in Snowman

    Adani Logistics, which held 26 percent equity stake in the company as of September 2020, sold 1.9 percent equity stake in Snowman in three consecutive sessions via open market transactions

  • Buy Indoco Remedies; target of Rs 352: Prabhudas Lilladher Nov 12, 2020 03:23 PM IST

    Buy Indoco Remedies; target of Rs 352: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Indoco Remedies has recommended buy rating on the stock with a target price of Rs 352 in its research report dated November 09, 2020.

  • Buy Indoco Remedies; target of Rs 335: ICICI Direct Nov 07, 2020 12:49 PM IST

    Buy Indoco Remedies; target of Rs 335: ICICI Direct

    ICICI Direct is bullish on Indoco Remedies has recommended buy rating on the stock with a target price of Rs 335 in its research report dated November 06, 2020.

  • Buy Indoco Remedies; target of Rs 330: ICICI Direct Aug 13, 2020 02:56 PM IST

    Buy Indoco Remedies; target of Rs 330: ICICI Direct

    ICICI Direct is bullish on Indoco Remedies has recommended buy rating on the stock with a target price of Rs 330 in its research report dated August 12, 2020.

Sections
ISO 27001 - BSI Assurance Mark